Deutsches Krebsforschungszentrum Stiftung Des Ffentlichen Rechts Universitt Heidelberg competitive analysis

Explore patent oppositions filed by Deutsches Krebsforschungszentrum Stiftung Des Ffentlichen Rechts Universitt Heidelberg against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Heterodimers Of Glutamic AcidMOLECULAR INSIGHT PHARMACEUTICALSSep 30, 2021

Explore Deutsches Krebsforschungszentrum Stiftung Des Ffentlichen Rechts Universitt Heidelberg's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 31, 2018Rspondins As Modulators Of Angiogenesis And Vasculogenesis1

Latest PTAB cases involving Deutsches Krebsforschungszentrum Stiftung Des Ffentlichen Rechts Universitt Heidelberg

Discover the latest PTAB cases involving Deutsches Krebsforschungszentrum Stiftung Des Ffentlichen Rechts Universitt Heidelberg, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Deutsches Krebsforschungszentrum Stiftung Des Ffentlichen Rechts Universitt Heidelberg with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES FFENTLICHEN RECHTS UNIVERSITT HEIDELBERG11 - -
MOLECULAR INSIGHT PHARMACEUTICALS - 4 - 1
PREDAZZI1 - - -